Thomas Colarusso

Co-founder & CEO

Bio-AI Health

A veteran business executive with 20 years’ experience who has a proven track record in developing life sciences and diagnostics businesses. He has held commercial leadership positions at companies including Definiens, PathAI & HalioDx. He was a key member of the Definiens commercial leadership team who build the tissue biomarker services business and subsequently sold the company to AstraZeneca Medimmune for $150m upfront payment + milestones in Nov 2014.

Thomas has extensive experience in developing technology platform businesses used to help improve and accelerate biomarker development, anatomical pathology, clinical trials and companion diagnostics assays used to aid patient selection for novel drug targeted therapy programs.

Other speakers in 2020


Dr. Evgeni Evgeniev

Research Attaché
Permanent Representation of Bulgaria to the European Union

United Kingdom

Andrew Fried

Healthcare and Life Sciences, Industry Leader
IBM Europe

The Netherlands

Erik Steinfelder

Biobanking Market Development Director
Thermo Fisher Scintific
Skip to content